INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2012

In clinical trials, cinnamon consumption has produced varying findings, with fasting glucose levels being the only consistently improved measurement.

This review evaluates the evidence and mechanisms of cinnamon for managing insulin resistance, metabolic syndrome, and type 2 diabetes. Human clinical trials have yielded mixed results; while some showed no benefits, others noted improvements in cholesterol, systolic blood pressure, insulin sensitivity, and postprandial glucose. However, the only outcome consistently improved by cinnamon consumption across trials was fasting glucose levels. The authors note it is premature to suggest cinnamon supplementation based on the current evidence, and systematic large-scale clinical trials are needed.

Study type
Narrative review
Who was studied
Human clinical trial participants and in vitro models
What was measured
Fasting glucose, postprandial glucose, insulin sensitivity, cholesterol, blood pressure

THE PAPER

Controversies surrounding the clinical potential of cinnamon for the management of diabetes.

Rafehi H, Ververis K, Karagiannis TC. Diabetes Obes Metab, 2012.

PubMed 22093965 ↗DOI 10.1111/j.1463-1326.2011.01538.x ↗

Diabetes & blood sugarBlood pressure

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.